Fed Rate Cut Prospects Dim as Jobs Data Signals Sticky Inflation QXO Launches Hostile Takeover Bid for Beacon After Repeated Rejections Dont Chase Returns Why ShortTerm Performance Often Leads to LongTerm Disappointment Post Office Horizon Scandal Police Inquiry Faces FiveYear Delay Without Additional Funding Mastercard Secures New York BitLicense Expanding Crypto Footprint Trumps Latest AIGenerated Posts Rekindle Greenland Interest Raising Geopolitical and Market Implications EDIT Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Higher GeoVax Labs Inc GOVX Q1 2026 Earnings NarrowerThanExpected Loss No Revenue Shares Slide ADT Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Decline MSA Safety Q1 2026 Earnings EPS Surpasses Estimates with Strong Operational Performance LITS Q4 2024 Earnings Significant EPS Miss Sends Shares Lower Paranovus Entertainment Technology Ltd PAVS Q2 2022 Earnings Wide EPS Miss Sends Shares Lower Laser Photonics Corporation LASE Surges 151 Tests Key Resistance at 10 AEye Inc LIDR Gains 37 as Shares Approach Key Resistance Atmus Filtration ATMU Edges Higher as Stock Holds Near Support Eyes Resistance at 5273 L3Harris Technologies LHX Edges Lower Amid Sector Rotation Key Levels in Focus Rising Dragon Acquisition Corp Rights RDACR Tumbles 17 as Price Nears Key Support White House and China Present Divergent Narratives on TrumpXi Summit Trade Deals Nokia Q1 2026 Earnings EPS Beats Estimates by 2285 as Cost Discipline Drives Profitability Blackrock Corporate High Yield Fund HYT Holds Steady at 850 Support and Resistance in Focus PSTV Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Clinical Development OXSQG Q1 2026 Earnings EPS Misses Estimates as Investment Income Falls Short CLDX Q1 2026 Earnings Slight EPS Miss as DevelopmentStage Biotech Continues NoRevenue Phase OnKure Therapeutics Inc OKUR Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline ANVS Q1 2026 Earnings WiderthanExpected Loss as Clinical Development Costs Persist Conduent Q1 2026 Earnings EPS Surprises Significantly Above Estimates Stock Surges JSPR Q1 2026 Earnings Stunning EPS Beat Highlights Cost Discipline as PreRevenue Biotech Advances Pipeline